Aqua Bio Technology ASA has appointed Geir Udnæs as the interim Chief Financial Officer, which is part of the company’s strategy to professionalize and strengthen its leadership amidst ...
Intelligent Bio Solutions Inc. (NYSE: GBS) recently reported significant adjustments in its outstanding shares following recent transactions. According to a Form 8-K filed with the Securities and ...
SAN DIEGO--(BUSINESS WIRE)--Iambic Therapeutics, a clinical-stage biotechnology company developing novel medicines using its AI-driven discovery and development platform, announced that Michael Secora ...
CFO Daily Each week day, senior reporter Sheryl Estrada offers an authoritative exploration of the latest trends and news impacting the corporate finance industry and the evolving role of today ...